Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quebec Precious Metals Corporation V.QPM

Alternate Symbol(s):  CJCFF

Quebec Precious Metals Corporation is a Canada-based gold explorer with a land position in the prospective Eeyou Istchee James Bay territory, Quebec, near Newmont Corporation’s Eleonore gold mine. The Company focuses on advancing its Sakami gold project and its newly discovered, drill-ready Ninaaskuwin lithium showing on the Elmer East project. In addition, the Company holds a 68% interest in the Kipawa rare earths project located near Temiscaming, Quebec. The Sakami project consists of one large contiguous block of 281 mineral claims and includes the contiguous claims, which are located 90 km northwest of the Eleonore mine, 570 km north of Val-d'Or and 900 km northwest of Montreal. The Cheechoo-Eleonore Trend project lies about 24 km northwest of the Eleonore mine. The Elmer East project consists of 929 claims, which is located along a trend from the recent Patwon Prospect gold discovery made by Azimut Exploration Inc. It also holds interest in the Matheson Joint Venture project.


TSXV:QPM - Post by User

Comment by cpacon Nov 29, 2004 1:10pm
138 Views
Post# 8242107

RE: volume

RE: volume>>with the volume going nuts, I agree that something is going to happen, but how can you put a share estimate when we can only guess what is drivng this?<< Pokeyno, as I've mentioned here before, if the stock price fell from the double digits due to the dropout due to increased incidence of nausea, and if they solve that problem, why would the stock not return to it's previous levels? Let us not forget that the drug reached it's endpoint in terms of efficacy. Many analysts believe CJC's drug to be a best in class Diabetes treatment. Cheers.
Bullboard Posts